中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2014年
14期
198-200
,共3页
老年%慢性心力衰竭%低钠血症%心功能
老年%慢性心力衰竭%低鈉血癥%心功能
노년%만성심력쇠갈%저납혈증%심공능
Elderly%Chronic heart failure%Hyponatremia%Cardiac function
目的：探讨老年慢性心力衰竭合并低钠血症的临床防治。方法2012年1月～2014年2月期间我院诊治的82例老年慢性心力衰竭合并低钠血症患者，作为观察组研究对象，另选同期82例老年慢性心力衰竭但不合并低钠血症患者，作为对照组研究对象，观察和比较两组病死率、住院时间、LVEF。将82例老年慢性心力衰竭合并低钠血症患者随机分为A组（常规抗心衰）和B组（常规抗心衰基础上，纠正低钠血症），对两组治疗后血钠水平、临床疗效，进行观察和比较。结果与对照组相比，观察组病死率（29.3% vs 11.0%）、住院时间（15.0±3.0）d vs（10.5±2.5）d明显升高，LVEF明显减少（36.5±0.1）%vs（43.7±0.1）%， P＜0.05；与A组相比，B组治疗后血钠水平（136.7±3.4）mmol/L vs（129.0±2.9）mmol/L及总有效率（73.2%vs 43.9%）明显提高，P＜0.05。结论对于老年慢性心力衰竭合并低钠血症患者，应在抗心衰治疗基础上，积极纠正低钠血症，改善患者的心功能及预后质量。
目的：探討老年慢性心力衰竭閤併低鈉血癥的臨床防治。方法2012年1月～2014年2月期間我院診治的82例老年慢性心力衰竭閤併低鈉血癥患者，作為觀察組研究對象，另選同期82例老年慢性心力衰竭但不閤併低鈉血癥患者，作為對照組研究對象，觀察和比較兩組病死率、住院時間、LVEF。將82例老年慢性心力衰竭閤併低鈉血癥患者隨機分為A組（常規抗心衰）和B組（常規抗心衰基礎上，糾正低鈉血癥），對兩組治療後血鈉水平、臨床療效，進行觀察和比較。結果與對照組相比，觀察組病死率（29.3% vs 11.0%）、住院時間（15.0±3.0）d vs（10.5±2.5）d明顯升高，LVEF明顯減少（36.5±0.1）%vs（43.7±0.1）%， P＜0.05；與A組相比，B組治療後血鈉水平（136.7±3.4）mmol/L vs（129.0±2.9）mmol/L及總有效率（73.2%vs 43.9%）明顯提高，P＜0.05。結論對于老年慢性心力衰竭閤併低鈉血癥患者，應在抗心衰治療基礎上，積極糾正低鈉血癥，改善患者的心功能及預後質量。
목적：탐토노년만성심력쇠갈합병저납혈증적림상방치。방법2012년1월～2014년2월기간아원진치적82례노년만성심력쇠갈합병저납혈증환자，작위관찰조연구대상，령선동기82례노년만성심력쇠갈단불합병저납혈증환자，작위대조조연구대상，관찰화비교량조병사솔、주원시간、LVEF。장82례노년만성심력쇠갈합병저납혈증환자수궤분위A조（상규항심쇠）화B조（상규항심쇠기출상，규정저납혈증），대량조치료후혈납수평、림상료효，진행관찰화비교。결과여대조조상비，관찰조병사솔（29.3% vs 11.0%）、주원시간（15.0±3.0）d vs（10.5±2.5）d명현승고，LVEF명현감소（36.5±0.1）%vs（43.7±0.1）%， P＜0.05；여A조상비，B조치료후혈납수평（136.7±3.4）mmol/L vs（129.0±2.9）mmol/L급총유효솔（73.2%vs 43.9%）명현제고，P＜0.05。결론대우노년만성심력쇠갈합병저납혈증환자，응재항심쇠치료기출상，적겁규정저납혈증，개선환자적심공능급예후질량。
Objective To study the clinical prevention and treatment about the elderly patients with chronic heart failure combined with hyponatremia. Methods The 82 elderly patients with chronic heart failure combined with hyponatremia in our hospital during the period from Jan 2012 to Feb 2014 were regarded as the subjects of the observation group, and the 82 patients with chronic heart failure without hyponatremia in the same period were regarded as the subjects of the control group. The fatality rate, hospitalization time, and LVEF in the two groups were observed and compared. The 82 elderly patients with chronic heart failure combined with hyponatremia were randomized into the A group(routine anti-heart failure) and the B group(based on the routine anti-heart failure, addition to the correction of hyponatremia). The blood sodium levels after the treatment and the clinical efficacy in the two groups were observed and compared. Results Compared with the control group, the fatality rate(29.3% vs 11.0%)and hospitalization time(15.0±3.0)d vs(10.5±2.5)d were significantly increased and the LVEF levels (36.5±0.1)%vs(43.7±0.1)%were obviously decreased in the observation group(P<0.05);compared with the A group, the blood sodium levels(136.7±3.4)mmol/L vs(129.0±2.9)mmol/L and the total effective rate(73.2%vs 43.9%)were significantly increased after treatment in the B group(P<0.05). Conclusion For the elderly patients with chronic heart failure combined with hyponatremia, the positive correction of hyponatremia based on the routine anti-heart failure treatment should done and then can improve the patients' cardiac function and prognosis quality.
